BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 33925279)

  • 1. Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.
    Chen S; Liu Y; Zhou H
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ubiquitin-specific peptidases in cancer progression.
    Young MJ; Hsu KC; Lin TE; Chang WC; Hung JJ
    J Biomed Sci; 2019 May; 26(1):42. PubMed ID: 31133011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of the highly homologous deubiquitinases ubiquitin specific peptidase 25 and 28: Insights into their pathophysiological and therapeutic roles.
    Zhou L; Qin B; Yassine DM; Luo M; Liu X; Wang F; Wang Y
    Biochem Pharmacol; 2023 Jul; 213():115624. PubMed ID: 37245535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Ubiquitin-specific Proteases in Hepatocellular Carcinoma Pathogenesis.
    Zhang X; Jin J; Cong J; Chen S; Wang T; Gao B; Huang G; Huang Z; Zhang J; Wang Z; Yang J
    Curr Top Med Chem; 2024; 24(3):179-191. PubMed ID: 38173207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin specific peptidases and prostate cancer.
    Guo Y; Cui S; Chen Y; Guo S; Chen D
    PeerJ; 2023; 11():e14799. PubMed ID: 36811009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin-Specific Proteases: Players in Cancer Cellular Processes.
    Cruz L; Soares P; Correia M
    Pharmaceuticals (Basel); 2021 Aug; 14(9):. PubMed ID: 34577547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ubiquitin-specific peptidases in glioma progression.
    Liang W; Fang J; Zhou S; Hu W; Yang Z; Li Z; Dai L; Tao Y; Fu X; Wang X
    Biomed Pharmacother; 2022 Feb; 146():112585. PubMed ID: 34968923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Mechanisms of DUBs Regulation in Signaling and Disease.
    Li Y; Reverter D
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of ubiquitin-specific peptidase 15 in systemic sclerosis fibroblasts increases response to transforming growth factor β.
    Galant C; Marchandise J; Stoenoiu MS; Ducreux J; De Groof A; Pirenne S; Van den Eynde B; Houssiau FA; Lauwerys BR
    Rheumatology (Oxford); 2019 Apr; 58(4):708-718. PubMed ID: 30608617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging potential of therapeutic targeting of ubiquitin-specific proteases in the treatment of cancer.
    Pal A; Young MA; Donato NJ
    Cancer Res; 2014 Sep; 74(18):4955-66. PubMed ID: 25172841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug resistance mechanisms and treatment strategies mediated by Ubiquitin-Specific Proteases (USPs) in cancers: new directions and therapeutic options.
    Gao H; Xi Z; Dai J; Xue J; Guan X; Zhao L; Chen Z; Xing F
    Mol Cancer; 2024 May; 23(1):88. PubMed ID: 38702734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity Based Profiling of Deubiquitylating Enzymes and Inhibitors in Animal Tissues.
    McLellan L; Forder C; Cranston A; Harrigan J; Jacq X
    Methods Mol Biol; 2016; 1449():411-9. PubMed ID: 27613053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin-specific peptidases: Players in bone metabolism.
    Shen J; Lin X; Dai F; Chen G; Lin H; Fang B; Liu H
    Cell Prolif; 2023 Aug; 56(8):e13444. PubMed ID: 36883930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinating enzyme inhibitors and their potential in cancer therapy.
    Crosas B
    Curr Cancer Drug Targets; 2014; 14(6):506-16. PubMed ID: 25088039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-β signaling pathway mediated by deubiquitinating enzymes.
    Kim SY; Baek KH
    Cell Mol Life Sci; 2019 Feb; 76(4):653-665. PubMed ID: 30349992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination: Friend and foe in cancer.
    Mansour MA
    Int J Biochem Cell Biol; 2018 Aug; 101():80-93. PubMed ID: 29864543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deubiquitinases and the new therapeutic opportunities offered to cancer.
    Pfoh R; Lacdao IK; Saridakis V
    Endocr Relat Cancer; 2015 Feb; 22(1):T35-54. PubMed ID: 25605410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structure and function of deubiquitinases: lessons from budding yeast.
    Suresh HG; Pascoe N; Andrews B
    Open Biol; 2020 Oct; 10(10):200279. PubMed ID: 33081638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin-specific proteases: From biological functions to potential therapeutic applications in gastric cancer.
    Li KQ; Bai X; Ke AT; Ding SQ; Zhang CD; Dai DQ
    Biomed Pharmacother; 2024 Apr; 173():116323. PubMed ID: 38401523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.
    Kubaichuk K; Kietzmann T
    Cells; 2019 Jun; 8(6):. PubMed ID: 31208103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.